Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Targeting HO-1 signaling pathway against dengue hemorrhagic fever

Jan. 21, 2022

SpFN vaccine confers protection in nonhuman primates against SARS-CoV-2

Jan. 21, 2022

BATF promotes lung tissue protection during acute respiratory virus infection

Jan. 20, 2022

PEGylated circularly permuted capsule depolymerase enzyme protects mice from anthrax infection

Jan. 18, 2022

Vir expands partnership with Gates Foundation in HIV and malaria

Jan. 17, 2022

Intranasal influenza-based boost vaccination for preventing SARS-CoV-2 infection

Jan. 17, 2022

Viral replication inhibitors patented by Gilead

Jan. 17, 2022

Machine learning approach speeds resistance identification

Jan. 17, 2022

Everest Medicines licenses global rights to EDDC's 3CL protease inhibitors to treat COVID-19

Jan. 14, 2022

RBD-PB6 RNA aptamer blocks SARS-CoV-2 entry into host cells

Jan. 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...